September 1, 2013
Jeremy Gilbert, Professor of Biomaterials was invited to become a member of the Orthopaedic and Rehabilitation Panel of the Medical Devices Committee of the Food and Drug Administration, a four year position he took up on September 1, 2013.
There are 18 panels on the Medical Devices Committee, making up a total of 122 voting members.
The role of the Medical Devices Committee is to review and evaluate data of the safety and effectiveness of marketed and investigational devices and to make recommendations for their regulation. Each Panel advises the Commissioner of Food and Drugs regarding recommended classification or reclassification of devices into one of three regulatory categories; advises on any possible risks to health associated with use of devices; advises on formulation of product development protocols; reviews pre-market approval applications for medical devices; reviews guidelines and guidance documents; recommends exemption of certain devices from the application of portions of the act; advises on the necessity to ban a device; and respond to requests from the agency to review and make recommendations on specific issues or problems concerning the safety and effectiveness of devices.
The SBI congratulates Dr. Gilbert on his appointment to the FDA.